Insulet CEO Ashley McEvoy Buys $160,000 Worth of Shares Amid Stock Decline

Ashley McEvoy, the President and CEO of Insulet Corporation (NASDAQ: PODD), purchased 1,100 shares for approximately $162,217 on August 21, 2026. This purchase occurred after a significant decline in the company’s stock price over recent months. The transaction increased McEvoy's direct holdings to 23,731 shares and added to his total equity stake valued at around $3.5 million as of market close on that day. Insulet Corporation is a leading medical device manufacturer with a strong presence in the insulin delivery systems market through its Omnipod platform. The company reported trailing twelve-month revenue of $3.05 billion and net income of $375.3 million, reflecting solid financial performance despite recent stock volatility.

By Brendan Coffey · Motley Fool ·

Insulet CEO Ashley McEvoy Buys $160,000 Worth of Shares Amid Stock Decline

Tickers: $PODD

Topics: corporate_governance stock_purchase

Read the full article at Motley Fool

More World news